Notably, TAK1 expression and activity were shown to be increased in murine PASMCs carrying a PAH-associated bmpr2 non-sense mutation but also in hypoxia and monocrotaline-induced PAH rat models, which display reduced levels of bmpr2 transcripts. Here, BMPR2 is linked to pulmonary arterial hypertension.